Document is current
Any future updates will be listed below
-
Authors
Lorentzen, Eliza H.
Nguyen, Kenny
Chen, Yu-Jen
King, Tari A.
Mittendorf, Elizabeth A.
Minami, Christina A.
-
Funding
Funding for this research was provided by:
Rob and Karen Hale Brigham and Women's Department of Surgery Research Fellowship
American Cancer Society
Rob and Karen Hale Endowed Chair in Surgical Oncology
Rob and Karen Hale Fund
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 3 March 2025
First Online: 21 March 2025
Disclosures
: TAK reports speaker honoraria for Exact Sciences and compensated service on the FES Steering Committee, GE Healthcare, compensated service as faculty for PrecisCa cancer information service and compensated service for Veractye. EAM reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. All other authors report no disclosures or conflicts of interest.
